Search by Journal
- HOME
- > Search by Journal
- > Japanese Society of Renal Cancer meeting program
Japanese Society of Renal Cancer meeting program
Volume 28, Issue suppl / 2004
English Article Japanese Article
- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Strategy to renal carcinoma prevention Hoyoku Nishino Japanese Society of Renal Cancer meeting program 28(suppl): 8-8, 2004. |
Specific expression of S100A1 in 1 renal cell carcinoma and S100A10 protein Tatsuya Takayama, Takayuki Sugiyama, 劉紅明, Seiichiro Osono, Akira Ishikawa 1, Teratani mechanic 2, 堂本知寛 3, 野沢龍嗣 3 Japanese Society of Renal Cancer meeting program 28(suppl): 9-9, 2004. |
Examination as the prognostic factor of the transforming growth factor-beta receptor in 2 renal cell carcinomas Tetsu Miyajima, Mototsugu Oya, Yutaka Horiguchi, Takeshi Nakagawa, Takashi Daito, Jun Nakajima, Takeshi Marumo, Masaru Murai Japanese Society of Renal Cancer meeting program 28(suppl): 10-10, 2004. |
Likelihood of the molecular target treatment with importance and EGFR specific inhibitor Gefitinib(Iressa) of EGFR in the extension of 3 renal cell carcinomas Morning dark circles Junichi, Makoto Sumitomo, Akio Horiguchi, Takako Asano, Yasunori Mizuguchi, Keiichi Ito, 木村文宏, Tomohiko Asano, Masamichi Hayakawa Japanese Society of Renal Cancer meeting program 28(suppl): 11-11, 2004. |
Immune therapy - second report - using 4 autoactivation γ delta type T cell 小林博人1), 中澤速和1), 田中義正2), 大坂行成1), 湊長博2), 東間紘1) Japanese Society of Renal Cancer meeting program 28(suppl): 12-12, 2004. |
Tailor maid peptide cancer vaccine therapy for 5 progress renal cell carcinomas case 西谷真明, 福森知治, Masayuki Takahashi, Hiroomi Kanayama, Ryo Yamada *, Takashi Mine *, Kyogo Ito * Japanese Society of Renal Cancer meeting program 28(suppl): 13-13, 2004. |
An immune escape mechanism and the blockade effect through B7-H1 from 6 human kidney cancer invasion lymphocytes Takahiro Wada, Nakanishi Toshiro, Shoichi Ueda, East Miyuki * Japanese Society of Renal Cancer meeting program 28(suppl): 14-14, 2004. |
Pathological examination of GVT in the mini-transplant mouse model of S1 renal cell carcinoma and invention of the GVHD reduction Masahiko Harano, Masatoshi Eto, Tategami Katsunori, Kazuya Omoto, Hiroshi Koga, Seiji Naito Japanese Society of Renal Cancer meeting program 28(suppl): 15-15, 2004. |
Experience of the nonmyeloablative allogeneic hematopoietic stem cell transplantation for the S2 metastasis-related renal carcinoma Kaku spring period 1), Takashi Senoo 4), Shin Ehara 2), Takashi Saiga 2), Tamotsu Nasu friend 2), 津島知靖 5), Hiromi Kumon 1), 2), Kazutoshi Aoyama 3), Hideo Kondo 3), Katsushi Shinagawa 3), Kinoura Katsuyuki 3), Kazu Ikeda truth 3), Tanimoto light sound 3) Japanese Society of Renal Cancer meeting program 28(suppl): 16-16, 2004. |
Experience of the marrow nondestructiveness-related allogeneic peripheral blood stem cell transplantation for the S3 metastasis-related renal carcinoma Satoshi Omori 1), Ryu Chikada Ichiro 1), Tomoaki Fujioka 1), Ishida Yoji 2) Japanese Society of Renal Cancer meeting program 28(suppl): 17-17, 2004. |
Experience - in RIST- Niigata University for S4 progress-related renal cell carcinoma Shunji Wakatsuki 1), Yoshihiko Tomita 2), Tsutomu Nishiyama 1), Your Shun Tanikawa 1), Kota Takahashi 1), Tatsuo Furukawa 2) Japanese Society of Renal Cancer meeting program 28(suppl): 18-18, 2004. |
Mini-transplant therapy for the S5 treatment-resistant renal carcinoma Heike Yuji 1), 2), Yuriko Morita 1), Asami Hosokawa 1), Kinuko Tajima 1), Rie Kojima 1), Your Akira Osozuka 1), 楠本茂 1), Yasushi Onishi 1), Shinichiro Mori 1), Upper Masahiro 1), Field Ryuji Nozaki 1), Kanari former 1), Kensei Tobinai 1), Hiroyuki Fujimoto 3), Naoki Matsuoka 3), Toru Nakagawa 3), Tadao Kakizoe 3), Yoichi Takaue 1) Japanese Society of Renal Cancer meeting program 28(suppl): 19-19, 2004. |
From immune gene therapy - tumor antigen peptide therapy for the gastrointestinal carcinoma to a gene therapy - Yutaka Yamagami machine Japanese Society of Renal Cancer meeting program 28(suppl): 20-20, 2004. |